Rocket Lab (RKLB) Stock Secures Three Additional Electron Missions as Wall Street Projects 30% Growth

Key Takeaways

• Rocket Lab has secured a new multi-launch agreement with iQPS for three additional Electron rocket missions, with launches beginning in 2028.
• The partnership now totals 15 missions, with seven launches already successfully completed since 2023.
• iQPS has placed its second multi-launch order with Rocket Lab within a six-month period.
• Wall Street analysts maintain a Moderate Buy rating on RKLB, with a consensus price target of $86.77 — representing approximately 30% potential upside.
• The upcoming Neutron rocket launch, anticipated in late 2026 or early 2027, is viewed as a significant growth catalyst for the company.

Rocket Lab has secured yet another contract with a loyal customer, and industry analysts are closely monitoring whether the aerospace company can translate this growth trajectory into improved profitability.

Rocket Lab USA, Inc., RKLB

The aerospace manufacturer revealed a fresh multi-launch contract with the Institute for Q-shu Pioneers of Space (iQPS) covering three more Electron rocket flights. These missions are slated to commence no earlier than 2028, launching from Launch Complex 1 located in New Zealand.

This agreement elevates the total number of missions between the two partners to 15. Of these, seven missions have already been successfully executed since 2023.

What’s particularly noteworthy is that iQPS has now placed two separate multi-launch contracts with Rocket Lab within just half a year. This pattern of recurring business demonstrates strong operational dependability and customer satisfaction.

The upcoming missions will carry QPS-SAR satellites into orbit utilizing Rocket Lab’s Motorized Lightband separation technology. Each mission will be entirely dedicated to iQPS payloads, ensuring focused delivery.

Brian Rogers, Vice President of Global Launch Services at Rocket Lab, emphasized that the partnership’s strength stems from the company’s proven track record on previous missions. The upcoming iQPS launch is scheduled for no earlier than May 2026.

In related financial developments, Rocket Lab recently concluded its at-the-market equity offering, securing approximately $474 million in gross proceeds. The company also maintains collared forward transaction agreements with potential maximum proceeds reaching $642 million.

Regarding corporate expansion, Rocket Lab obtained German regulatory clearance for its anticipated acquisition of Mynaric. The transaction is projected to finalize in April with a valuation of roughly $75 million.

Neutron Takes Center Stage

The company generated $601.8 million in revenue over the trailing twelve months, marking a 38% year-over-year increase. However, market analysts emphasize that the real narrative revolves around what’s on the horizon — the Neutron rocket.

This 43-meter partially reusable launch vehicle is engineered to rival SpaceX’s Falcon 9 in the satellite and cargo deployment market. Critical components, including the distinctive “Hungry Hippo” fairing and thrust structure, have been completed and are prepared for final integration.

Clear Street analyst Gregory Pendy noted that Neutron could access a substantially larger market segment and produce higher revenue per launch compared to Electron — positioning it as a primary growth engine if development timelines are maintained.

Wall Street’s Perspective

Citizens analyst Trevor J. Walsh elevated RKLB from Hold to Buy this week, maintaining his $85 price target. Walsh described the current valuation as an appealing entry opportunity and emphasized Rocket Lab’s strategic expansion into defense and space services as a route to enhanced profit margins.

Sujeeva De Silva from Roth MKM sustained a Buy rating with a $90 price objective. De Silva drew attention to Rocket Lab’s expanding contract backlog and its diversification into satellite components as proof that the company is effectively broadening its business model beyond launch services.

Overall, RKLB carries a Moderate Buy consensus rating on TipRanks — comprising 10 Buy ratings and 5 Hold ratings issued over the past three months. The consensus price target stands at $86.77, suggesting approximately 30% upside potential from current trading levels.

RKLB shares declined 3.39% on the day the announcement was made.

The post Rocket Lab (RKLB) Stock Secures Three Additional Electron Missions as Wall Street Projects 30% Growth appeared first on Blockonomi.